Loading...

PE anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PE_071608.jpg
C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_071608.jpg
    C57BL/6 mouse splenocytes stained with IM7 PE
  • IM7_PE_human
    Human peripheral blood lymphocytes stained with IM7 PE
See PE spectral data
Cat # Size Price Quantity Check Availability Save
103023 25 tests 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103007 50 µg 45€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103024 100 tests 94€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103008 200 µg 117€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse,Human
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
µg sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. For µg sizes, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Li P, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.24. PubMed
  2. Trial J, et al. 2017. Basic Research in Cardiology. 10.1007/s00395-017-0623-4. PubMed
  3. Pardo E, et al. 2017. PLoS One. 12(6):e0177472. PubMed
  4. Hammer A, et al. 2017. J Neuroinflammation. 10.1186/s12974-017-0954-y. PubMed
  5. Hammer A, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01922. PubMed
  6. Zhao J, et al. 2018. Stem Cell Reports. 10:180. PubMed
  7. Li P, et al. 2018. J Cell Mol Med. 22:3423. PubMed
  8. Yip HYK, et al. 2018. PLoS One. 3. PubMed
  9. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  10. Biton M et al. 2018. Cell. 175(5):1307-1320 . PubMed
  11. Wang D, et al. 2018. Immunity. 48:659. PubMed
  12. Lu H, et al. 2019. EBioMedicine. 40:276. PubMed
  13. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  14. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  15. Yue X, et al. 2019. Nat Commun. 10:2011. PubMed
  16. Qi X, et al. 2019. Nat Commun. 10:2141. PubMed
  17. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  18. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  19. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  20. Zhang Z, et al. 2019. Cell Death Dis. 10:530. PubMed
  21. Yang C, et al. 2019. Nat Commun. 10:3931. PubMed
  22. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  23. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  24. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  25. Shao B, et al. 2019. J Immunol. 10.4049/jimmunol.1900680. PubMed
  26. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  27. Du L et al. 2019. Cell metabolism. 29(6):1363-1375 . PubMed
  28. Santos CP et al. 2019. Nat Commun. 10(1):4407 . PubMed
  29. Kälin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  30. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  31. Velazquez VM, et al. 2017. Mol Ther Methods Clin Dev. 0.277083333. PubMed
  32. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  33. Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
  34. Upasani V, et al. 2019. Front Immunol. 2.152777778. PubMed
  35. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  36. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  37. Shi Y, et al. 2020. Med Sci Monit. 26:e923328. PubMed
  38. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  39. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  40. Yeung F, et al. 2020. Cell Host & Microbe. 27(5):809-822. PubMed
  41. Ge C, et al. 2020. Cell Reports. 29(13):4236-4244.e3.. PubMed
  42. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  43. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  44. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  45. Morley S, et al. 2008. J Immunol. 181:4696. PubMed
  46. Chen Y, et al. 2010. Mol Cancer Ther. 2.374305556. PubMed
  47. Sentman A 2011. Blood. 117:6571. PubMed
  48. Lee Y, et al. 2012. Nat Immunol. 13:991. PubMed
  49. Blacking T, et al. 2011. Vet Immunol Immunopathol. 141:46. PubMed
  50. Shao W, et al. 2010. Transplant Proc. 42:2777. PubMed
  51. Tyne A, et al. 2013. Vaccine. 31:4322. PubMed
  52. MacDonald K, et al. 2014. J Immunol. 192:3180. PubMed
  53. Davila S, et al. 2014. J Immunol. 192:4284. PubMed
  54. Saenz F, et al. 2014. PLoS One. 9:97666. PubMed
  55. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  56. Charlton J, et al. 2015. PLoS One. 10:119200. PubMed
  57. Bonaccorsi-Riani E, et al. 2015. PLoS One. 10: 0136106. PubMed
  58. Olguín J, et al. 2015. Microbes Infect. 17: 586-595. PubMed
  59. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  60. Fiume G, et al. 2015. Sci Rep. 5: 13864. PubMed
  61. MaruYama T, et al. 2015. J Leukoc Biol. 98: 385-393. PubMed
  62. Kaji T, et al. 2016. Int Immunol. 28: 267 - 282. PubMed
  63. Rezende R, et al. 2015. Nat Commun. 6: 8726. PubMed
  64. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  65. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  66. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  67. M H, et al. 2016. Open Bio. 6: 150208. PubMed
  68. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  69. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  70. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  71. Hammer A, et al. 2016. Proc Natl Acad Sci U S A. 113(49):14109-14114. PubMed
  72. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  73. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  74. Shapiro MR, et al. 2020. Front Immunol. 1.972222222. PubMed
  75. Fu X, et al. 2020. Aging (Albany NY). 12:15656. PubMed
  76. Yi X, et al. 2020. Sci Adv. 6:eaba3546. PubMed
  77. Chulpanova DS, et al. 2020. Bioengineering (Basel). 7:00. PubMed
  78. Yermanos A, et al. 2020. Front Immunol. 1.143055556. PubMed
  79. Isakova-Sivak I, et al. 2020. Vaccines (Basel). 8:00. PubMed
  80. Kong T, et al. 2020. Cancer Res. 80:444. PubMed
  81. Girón-Pérez DA, et al. 2020. J Cell Sci. 133:00:00. PubMed
  82. Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed
  83. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  84. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  85. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  86. Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
  87. Korin B, et al. 2020. Sleep. :43. PubMed
  88. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  89. Velletri T, et al. 2020. Cell Death Differ. . PubMed
  90. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  91. Xu Y, et al. 2020. Stem Cells Int. 8894449:2020. PubMed
  92. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  93. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  94. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
  95. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  96. Yue X, et al. 2021. EMBO Rep. 22:e52716. PubMed
  97. Zhang Q, et al. 2021. Nat Commun. 12:4592. PubMed
  98. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  99. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  100. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
  101. Zhang Q, et al. 2021. Bone Joint Res. 10:226. PubMed
  102. Bian X, et al. 2021. Clin Transl Med. 11:e352. PubMed
  103. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  104. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  105. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  106. Sandborn WJ, et al. 2021. Gastroenterology. 161:1853. PubMed
  107. Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
  108. Herbst SA, et al. 2021. iScience. 24:103062. PubMed
  109. Yue T, et al. 2022. Cell Death Differ. 29:218. PubMed
  110. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  111. Wu J, et al. 2021. STAR Protoc. 2:101022. PubMed
  112. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  113. Volpedo G, et al. 2022. NPJ Vaccines. 7:32. PubMed
  114. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  115. Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
  116. Nair S, et al. 2021. JCI Insight. 6:. PubMed
  117. De Ponte Conti B, et al. 2021. Elife. 10:. PubMed
  118. Seo MS, et al. 2021. Vet Sci. 8:. PubMed
  119. Wang S, et al. 2021. Parasite. 28:13. PubMed
  120. Shaikh H, et al. 2021. Front Immunol. 12:689896. PubMed
  121. Wang Y, et al. 2021. Nat Commun. 12:4964. PubMed
  122. Sung SE, et al. 2021. Vet Sci. 8:. PubMed
  123. Gabriely G, et al. 2021. iScience. 24:103347. PubMed
  124. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  125. Di Lorenzo A, et al. 2022. Oncoimmunology. 11:2086752. PubMed
  126. Kwok T, et al. 2022. Front Aging. 3:838943. PubMed
  127. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  128. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  129. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  130. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  131. Yang W, et al. 2020. Methods Mol Biol. 2111:91. PubMed
  132. Mardomi A, et al. 2021. J Cell Physiol. 236:6328. PubMed
  133. Sottnik JL, et al. 2021. Cancer Res. 81:2833. PubMed
  134. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  135. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  136. Melhem H, et al. 2022. Mucosal Immunol. 15:443. PubMed
  137. Yang C, et al. 2022. Cancers (Basel). 14:. PubMed
  138. Tsuchihashi K, et al. 2022. Biochem Biophys Rep. 30:101246. PubMed
  139. Xu F, et al. 2022. Cell Death Discov. 8:142. PubMed
  140. Ngamsri KC, et al. 2022. Cells. 11:. PubMed
  141. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  142. Knizkova D, et al. 2022. Nat Immunol. 23:1644. PubMed
  143. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  144. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  145. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  146. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  147. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  148. Hu X, et al. 2022. EBioMedicine. 86:104333. PubMed
  149. Gilazieva Z, et al. 2022. Curr Issues Mol Biol. 44:5363. PubMed
  150. Dölz M, et al. 2022. iScience. 25:105372. PubMed
  151. Zhu J, et al. 2022. Nat Commun. 13:7466. PubMed
  152. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  153. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  154. Zhu H, et al. 2022. Cell Transplant. 31:9636897221106996. PubMed
  155. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  156. Scanlon VM, et al. 2022. Sci Rep. 12:16218. PubMed
  157. Ou W, et al. 2023. Nat Commun. 14:392. PubMed
  158. Lu C, et al. 2023. Antiviral Res. 212:105556. PubMed
  159. Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed
  160. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  161. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  162. Tada T, et al. 2023. JCI Insight. 8:. PubMed
  163. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  164. Huang T, et al. 2023. Front Immunol. 14:1124152. PubMed
  165. A R, et al. 2023. Front Oncol. 13:1147668. PubMed
  166. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  167. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  168. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  169. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
RRID
AB_493686 (BioLegend Cat. No. 103023)
AB_312958 (BioLegend Cat. No. 103007)
AB_493687 (BioLegend Cat. No. 103024)
AB_312959 (BioLegend Cat. No. 103008)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 4    Revision Date: 10-15-2015

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account